Skip to content

Caloric Restriction, Exercise, and Glucoregulation in Humans

Caloric Restriction, Exercise, and Glucoregulation in Humans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00777621
Acronym
CREG
Enrollment
69
Registered
2008-10-22
Start date
2008-04-30
Completion date
2015-03-31
Last updated
2016-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Weight loss induced by caloric restriction alone (CR) and by exercise alone (EX) result in similar effects on blood glucose and insulin. The purpose of this study is to assess the hypothesis that weight loss through caloric restriction plus exercise will result in greater improvements on glucose tolerance and insulin action than similar weight losses through CR or EX alone.

Detailed description

Participants are randomized into caloric restriction, exercise, and caloric restriction plus exercise weight loss groups. Measurements of blood glucose and insulin, oral glucose tolerance, and matched glucose infusion will be done at baseline and after weight loss of 6% of body weight. Other tests include maximal oxygen uptake (VO2max), strength tests, blood pressure, blood lipids, serum inflammatory markers, dual X-ray absorptiometry (DEXA) for bone density and body composition, physical activity levels, dietary intakes, and measures of arterial stiffness.

Interventions

OTHERCalorie Restriction

This group will undergo a 20% reduction in energy intake without any change in energy expenditure.

OTHERExercise

This group will undergo a 20% increase in energy expenditure by exercising without any change in energy intake.

OTHERCalorie Restriction and Exercise

This group will undergo 10% reduction in energy intake and a 10% increase in energy expenditure via exercise.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
St. Louis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* females postmenopausal * no diabetes, cardiovascular disease, cancer * no orthopedic problems * not currently exercising * BMI between 25 and 29.9 * nonsmokers

Exclusion criteria

* current regular exercisers * premenopausal women * cardiovascular disease, lung disease, cancer, diabetes

Design outcomes

Primary

MeasureTime frame
Glucoregulatory function3-4 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026